EQT acquires Qiagen for over $10 billion
Statements (10 of 13)
- Neutral
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
- Bullish
EQT is nearing a $9.6 billion deal to acquire Qiagen for molecular testing
- Bullish
EQT is offering to acquire Qiagen for a financial investment
- Neutral
EQT and KKR are competing for interest in the diagnostic company Qiagen.
- Neutral
EQT is in advanced negotiations to acquire Qiagen for over $10 billion
- Bullish
A competitor is also submitting an acquisition offer for Qiagen.
- Bullish
EQT is offering an acquisition offer for Qiagen.
- Bullish
Qiagen's shares benefited from new takeover speculation.
- Neutral
EQT is in advanced talks to buy Qiagen for a testing firm
- Neutral
EQT is in negotiations to acquire Qiagen, a German medical technology company.
3 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=66a6033c-6a1f-47d3-84b3-1b26f6985e65 Get a free API key ↗